โ Best Covered Calls
/ ALNY
ALNY Covered Call Analysis: Proceed With Caution Weak ยท 45/100
Alnylam Pharmaceuticals Inc (Healthcare) ยท $148.30 ยท
Analysis generated Nov 20, 2026 ยท
Data as of market close Nov 20
ยท Market closed โ data may be from last trading day
This strategy is NOT recommended for ALNY right now
Score 45/100. The technical signals do not support selling covered calls on ALNY at this time.
RSI at 30 โ oversold, not ideal for selling calls. IV -13% vs avg โ premiums near average, acceptable. ADX at 35 โ strong trend, stock may run past strike.
Check back when conditions improve, or consider a different strategy.
Quick Take
ALNY is trading at $148.30 with RSI at 30 (oversold territory). Options IV is at 52% โ 13% below its 30-day average of 59%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.
Technical Signals
RSI (14)
30
IV Today
51.5%
IV vs 30d Avg
-13%
MACD
bullish
ADX
35
MFI
48
The Setup
ALNY Covered Call
LONG STOCK
100 shares @ $148.3
SHORT CALL
$160 Jan '27 ยท $7.71/sh
Net Cost
$14,059
Max Profit
+$1,941
Break-even
$140.59
Projected P&L at Target
+$1,941
(13.8%)
P&L at Expiry
P&L Scenarios
What happens at different ALNY prices by expiry:
| ALNY Price | Today | +3d (Nov 24) | +7d (Nov 28) | Dec 9 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $119 (-20%) | -$2,285 | -$2,274 | -$2,261 | -$2,228 | -$2,198 | -$2,195 |
| $126 (-15%) | -$1,628 | -$1,612 | -$1,591 | -$1,535 | -$1,467 | -$1,453 |
| $133 (-10%) | -$1,023 | -$1,000 | -$970 | -$886 | -$761 | -$712 |
| $141 (-5%) | -$478 | -$449 | -$410 | -$298 | -$103 | +$29 |
| $145 (-2%) | -$183 | -$151 | -$107 | +$20 | +$255 | +$474 |
| $148 (0%) โ now | -$0 | +$34 | +$80 | +$216 | +$476 | +$771 |
| $151 (+2%) | +$171 | +$207 | +$255 | +$398 | +$679 | +$1,068 |
| $156 (+5%) | +$407 | +$444 | +$495 | +$646 | +$949 | +$1,513 |
| $160 (+8%) โ target | +$616 | +$654 | +$707 | +$862 | +$1,177 | +$1,941 |
| $163 (+10%) | +$743 | +$781 | +$834 | +$991 | +$1,306 | +$1,941 |
| $171 (+15%) | +$1,015 | +$1,052 | +$1,104 | +$1,256 | +$1,553 | +$1,941 |
| $178 (+20%) | +$1,229 | +$1,264 | +$1,313 | +$1,454 | +$1,711 | +$1,941 |
Why This Strategy, Why Now
- RSI at 30 โ oversold, not ideal for selling calls
- IV -13% vs avg โ premiums near average, acceptable
- MACD bullish โ stock has upward momentum
- ADX at 35 โ strong trend, stock may run past strike
- No squeeze โ no imminent breakout
Key Risks
ALNY has bullish momentum (MACD). If a positive catalyst emerges (earnings beat, product launch), the stock could gap past your strike. Consider rolling the call up if ALNY approaches the strike before expiry.
ADX at 35 indicates a moderately strong trend. In trending markets, covered calls cap your upside too early. Use a higher strike to leave more room.